Athena Countouriotis M.D.

Athena Countouriotis MD is currently serving as the Director at Capstan Therapeutics. They are also the Co-Founder and Chief Executive Officer at Avenzo Therapeutics. In addition to these roles, they hold director positions at Recludix Therapeutics, Leal Therapeutics, Passage Bio, and Iovance Biotherapeutics, Inc. Prior to these positions, they have also worked as the President and Chief Executive Officer at Turning Point Therapeutics, as well as in various executive roles at Adverum Biotechnologies, Inc. and Halozyme Therapeutics, Inc. Athena Countouriotis MD graduated from Tufts University School of Medicine with a Doctor of Medicine degree.